In the specialized field of biochemical research, the WKYMVm peptide has emerged as a subject of significant interest due to its unique structural properties and its role as a potent signaling molecule. As someone who follows advancements in peptide science, I have found the exploration of this hexapeptide to be a fascinating journey into how synthetic compounds interact with cellular pathways.
Biochemical Profile and Structural Significance
The WKYMVm peptide—often referred to as the "W-peptide"—is a synthetic hexapeptide with the sequence H-Trp-Lys-Tyr-Met-Val-Met-NH2. Its molecular weight is approximately 856.13 g/mol, and it is commonly synthesized as a trifluoroacetate (TFA) salt to ensure stability and high purity (typically ≥95% via HPLC).
From a structural perspective, the molecule is notable for its interaction with the Formyl Peptide Receptor (FPR) family. Specifically, WKYMVm is a selective agonist for formyl peptide receptors, including FPR1, by BQ Li·2001·Cited by 85—The synthetic peptideWKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.Read more FPR2 (formerly known as FPRL1), and FPR3. The crystal structure of FPR2 bound to this potent peptide agonist has been documented at a 2.8 Å resolution, providing a clear view of how it adopts an active conformation to trigger cellular responses.
Mechanisms of Action: How WKYMVm Functions
The primary interest in this compound stems from the fact that WKYMVm is a selective agonist for the formyl peptide receptors and WKYMVm participates in the regulation of immune cells. When investigating its biological activity, researchers often look at the following parameters:
* FPR Affinity: It exhibits high potency, with EC50 values in the picomolar range (e.g., 75 pM for FPR1/FPR2) and nanomolar range (e.g., 3 nM for FPR3).
* Intrace by Y Le·1999·Cited by 236—Trp-Lys-Tyr-Val-d-Met (WKYMVm) is a synthetic leukocyte-activating peptide postulated to use seven-transmembrane, G protein-coupled receptor(s). In the study to Read more llular Signaling: Upon binding, the peptide induces Ca2+ mobilization and stimulates phospholipase C (PLC)-mediated formation of inositol phosphates (InoPs).
* Leukocyte Modulation: As a potent chemoattractant, it enhances leukocyte activity, particularly in neutrophils and monocytes.
Because WKYMVm is a synthetic WKYMVm is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, and also activate phosphoinositide hydrolysis in undifferentiated HL-60 cells. peptide agonist, it is frequently utilized in controlled settings to study how cells by Y Le·1999·Cited by 236—Trp-Lys-Tyr-Val-d-Met (WKYMVm) is a synthetic leukocyte-activating peptide postulated to use seven-transmembrane, G protein-coupled receptor(s). In the study to Read more respond to chemotactic signals. This includes observing how neutrophils are activated by WKYMVM through FPRL1/FPR2 pathways, which is critical for understanding the mechanics of cell migration and survival.
Observations on Biological Interactions
In my review of current literature, it is evident that WKYMVm is a selective formylpeptide receptor 2 (FPR2) agonist that exhibits pro-angiogenic and anti-inflammatory properties. These attributes are central to its reputation in research circles.
Furthermore, WKYMVm plays an anti-inflammatory role in most inflammatory diseases by modulating the behavior of phagocytes. Studies have indicated that the pep The effect of the WKYMVm peptide on promoting mBMSC tide can influence neutrophil phagocytosis through specific signaling pathways, such as IRFs/STAT1. By acting as an immune stimulating peptide, it serves as a valuable tool for those examining how targeted receptor activation can alter the secretion of inflammatory mediators.
Practical Considerations for Research
For those interested in the technical nuances of the WKYMVm peptide, it is important to distinguish between its isomers, such Therapeutic potential of WKYMVm in diseases as the diastereomer Trp-Lys-Tyr-Val-D-Met (WKYMVm), which interacts with all three types of FPRs. Whether you are searching for a Wkymvm peptide fpr2 specific reagent or exploring general Wkymvm peptide levels in experimental models, the consistency of the peptide sequence is paramount.
When sourcing this peptide, researchers should prioritize providers that offer high-purity, synthetic versions, as the biological activity is highly dependent on the correct amidation of the C-terminus. The WKYMVM is a synthetic hexapeptide that acts as an agonist of FPR2 and FPR3, and its experimental utility is br by I Lice·2022·Cited by 6—The hexapeptideWKYMVM acts as an agonist of FPR2 and FPR3, whereas its diastereomer WKYMVm interacts with the three types of FPR [6,7]. These Read more oad—ranging from studying its ability to promote exosome secretion in mesenchymal stem cells to its capacity to attenuate the function of chemokine receptors like CCR5 Induces Ca2+mobilization and superoxide productionin, and chemotaxic migration of, monocytes and neutrophils. Also promotes monocyte survival through a PKC-, Read more and CXCR4.
In summary, the WKYMVm peptide remains a cornerstone of G protein-coupled receptor (GPCR) research. Its ability to serve as a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist provides researchers with a robust, reliable tool for investigating the complex dynamics of cellular signaling and immune regulation in a non-clinical, academic environment.